Shilpi Arora

1.9k total citations
31 papers, 948 citations indexed

About

Shilpi Arora is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Shilpi Arora has authored 31 papers receiving a total of 948 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Shilpi Arora's work include RNA Interference and Gene Delivery (7 papers), Epigenetics and DNA Methylation (6 papers) and MicroRNA in disease regulation (4 papers). Shilpi Arora is often cited by papers focused on RNA Interference and Gene Delivery (7 papers), Epigenetics and DNA Methylation (6 papers) and MicroRNA in disease regulation (4 papers). Shilpi Arora collaborates with scholars based in United States, India and Canada. Shilpi Arora's co-authors include David O. Azorsa, Nootan Kumar Shukla, Ranju Ralhan, Suryanaryana V.S. Deo, Ashish Choudhary, Ajay Matta, Kristen Bisanz, Glen J. Weiss, Shravan Sridhar and Saynur Vardar‐Şengül and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Shilpi Arora

29 papers receiving 930 citations

Peers

Shilpi Arora

ONCOL

PRM

HEMAT

Changxian Shen United States

Justine Y. Bruce United States

Ivan Vrhovec Slovenia

Zibin Jiang United States

Michaela Medová Switzerland

Rika Tsuchida Japan

Zi‐Jie Long China

Chirayu Patel United States

Fábio Pittella Silva Brazil

Joseph A. Bokar United States

Changxian Shen United States

Shilpi Arora

684 ×1.0

288 ×1.1

296 ×1.1

ONCOL

167 ×1.7

PRM

24 ×0.3

HEMAT

Citations per year, relative to Shilpi Arora Shilpi Arora (= 1×) peers Changxian Shen

Countries citing papers authored by Shilpi Arora

Since Specialization

Citations

This map shows the geographic impact of Shilpi Arora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shilpi Arora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shilpi Arora more than expected).

Fields of papers citing papers by Shilpi Arora

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shilpi Arora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shilpi Arora. The network helps show where Shilpi Arora may publish in the future.

Co-authorship network of co-authors of Shilpi Arora

This figure shows the co-authorship network connecting the top 25 collaborators of Shilpi Arora. A scholar is included among the top collaborators of Shilpi Arora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shilpi Arora. Shilpi Arora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Arora, Shilpi, et al.. (2022). Chronotherapeutic Drug Delivery Systems – An Approach in the Management of Diseases Based on Circadian Rhythm. ECS Transactions. 107(1). 8915–8922.

Stuckey, Jacob I., Nico Cantone, Alexandre Côté, et al.. (2021). Identification and characterization of second-generation EZH2 inhibitors with extended residence times and improved biological activity. Journal of Biological Chemistry. 296. 100349–100349. 9 indexed citations

McGrath, John P., Kaylyn E. Williamson, Srividya Balasubramanian, et al.. (2016). Pharmacological Inhibition of the Histone Lysine Demethylase KDM1A Suppresses the Growth of Multiple Acute Myeloid Leukemia Subtypes. Cancer Research. 76(7). 1975–1988. 70 indexed citations

Azorsa, David O. & Shilpi Arora. (2016). High-Throughput RNAi Screening. Methods in molecular biology. 3 indexed citations

Weiss, Glen J., Winnie S. Liang, Tyler Izatt, et al.. (2012). Paired Tumor and Normal Whole Genome Sequencing of Metastatic Olfactory Neuroblastoma. PLoS ONE. 7(5). e37029–e37029. 28 indexed citations

Arora, Shilpi, Ronald L. Korn, Elizabeth Lenkiewicz, et al.. (2012). Clonal Evolution of a Case of Treatment Refractory Maxillary Sinus Carcinoma. PLoS ONE. 7(9). e45614–e45614. 1 indexed citations

Marlow, Laura A., Christina A. Von Roemeling, Simon Cooper, et al.. (2012). Foxo3a drives proliferation in anaplastic thyroid carcinoma via transcriptional regulation of cyclin A1: A paradigm shift that impacts current therapeutic strategies. Journal of Cell Science. 125(Pt 18). 4253–63. 30 indexed citations

Henderson, Meredith C., Shilpi Arora, Ashish Choudhary, et al.. (2011). High-throughput RNAi Screening Identifies a Role for TNK1 in Growth and Survival of Pancreatic Cancer Cells. Molecular Cancer Research. 9(6). 724–732. 26 indexed citations

Savas, Sevtap, David O. Azorsa, Hamdi Jarjanazi, et al.. (2011). NCI60 Cancer Cell Line Panel Data and RNAi Analysis Help Identify EAF2 as a Modulator of Simvastatin and Lovastatin Response in HCT-116 Cells. PLoS ONE. 6(4). e18306–e18306. 14 indexed citations

10.

Allen, Kristi, Chris Kingsley, Irene Cherni, et al.. (2011). Hedgehog signaling pathway molecules and ALDH1A1 expression in early-stage non-small cell lung cancer. Lung Cancer. 76(2). 191–196. 43 indexed citations

11.

Arora, Shilpi, Aarati R. Ranade, Nhan L. Tran, et al.. (2011). MicroRNA‐328 is associated with (non‐small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration. International Journal of Cancer. 129(11). 2621–2631. 149 indexed citations

12.

Arora, Shilpi, Christian Beaudry, Kristen Bisanz, et al.. (2010). A High-Content RNAi-Screening Assay to Identify Modulators of Cholesterol Accumulation in Niemann–Pick Type C Cells. Assay and Drug Development Technologies. 8(3). 295–319. 12 indexed citations

13.

Tüzmen, Şükrü, et al.. (2010). RNAi-Based Functional Pharmacogenomics. Methods in molecular biology. 700. 271–290. 3 indexed citations

14.

Kaiser, Christine, Nathalie Meurice, Shilpi Arora, et al.. (2010). Chemogenomic Analysis Identifies Macbecin II as a Compound Specific for SMAD4‐Negative Colon Cancer Cells. Chemical Biology & Drug Design. 75(4). 360–368. 3 indexed citations

15.

Arora, Shilpi, Kristen Bisanz, Gargi D. Basu, et al.. (2010). RNAi screening of the kinome identifies modulators of cisplatin response in ovarian cancer cells. Gynecologic Oncology. 118(3). 220–227. 48 indexed citations

16.

Azorsa, David O., Gargi D. Basu, Ashish Choudhary, et al.. (2009). Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancer. Journal of Translational Medicine. 7(1). 43–43. 82 indexed citations

17.

Vardar‐Şengül, Saynur, Shilpi Arora, Haluk Baylas, & Dan Mercola. (2009). Expression Profile of Human Gingival Fibroblasts Induced by Interleukin‐1β Reveals Central Role of Nuclear Factor‐Kappa B in Stabilizing Human Gingival Fibroblasts During Inflammation. Journal of Periodontology. 80(5). 833–849. 40 indexed citations

18.

Arora, Shilpi, Yipeng Wang, Zhenyu Jia, et al.. (2008). Egr1 regulates the coordinated expression of numerous EGF receptor target genes as identified by ChIP-on-chip. Genome biology. 9(11). R166–R166. 38 indexed citations

19.

Reis, Patrícia P., Igor Jurišica, Shilpi Arora, et al.. (2004). Molecular classification of oral cancer by cDNA microarrays identifies overexpressed genes correlated with nodal metastasis. International Journal of Cancer. 110(6). 857–868. 52 indexed citations

20.

Reis, Patrícia P., Antti Mäkitie, Mahadeo A. Sukhai, et al.. (2004). Current Applications of Microarrays in Head and Neck Cancer Research. The Laryngoscope. 114(2). 241–248. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact